Reiff, S. D., Muhowski, E. M., Guinn, D., Lehman, A., Fabian, C. A., Cheney, C., . . . Woyach, J. A. (2018). Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: A new treatment strategy for ibrutinib-resistant CLL. Blood.
Styl cytowania ChicagoReiff, Sean D., et al. "Noncovalent Inhibition of C481S Bruton Tyrosine Kinase By GDC-0853: A New Treatment Strategy for Ibrutinib-resistant CLL." Blood 2018.
Styl cytowania MLAReiff, Sean D., et al. "Noncovalent Inhibition of C481S Bruton Tyrosine Kinase By GDC-0853: A New Treatment Strategy for Ibrutinib-resistant CLL." Blood 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..